Nautilus Biotechnology, Inc. (NAUT) Earnings History
Annual and quarterly earnings data from 2018 to 2025
Loading earnings history...
NAUT EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
NAUT Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
Download Data
Export NAUT earnings history in CSV or JSON format
Free sign-in required to download data
Nautilus Biotechnology, Inc. (NAUT) Earnings Overview
As of May 8, 2026, Nautilus Biotechnology, Inc. (NAUT) reported trailing twelve-month net income of -$57M, reflecting +16.1% year-over-year growth. The company earned $-0.45 per diluted share over the past four quarters.
Looking at the long-term picture, NAUT's historical earnings data spans multiple years. The company achieved its highest annual net income of $627M in fiscal 2018.
Nautilus Biotechnology, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including CDNA (-$8M net income, -5.6% margin), SEER (-$79M net income, -620.9% margin), QBTS (-$355M net income, -1444.1% margin), NAUT has comparable earnings metrics. Compare NAUT vs CDNA →
NAUT Earnings vs Peers
Earnings metrics vs comparable public companies
NAUT Historical Earnings Data (2018–2025)
8 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$59M | +16.6% | -$67M | $-0.47 | - | - |
| 2024 | -$71M | -11.2% | -$81M | $-0.56 | - | - |
| 2023 | -$64M | -9.9% | -$76M | $-0.51 | - | - |
| 2022 | -$58M | -15.1% | -$64M | $-0.46 | - | - |
| 2021 | -$50M | -222.1% | -$50M | $-0.60 | - | - |
| 2020 | -$16M | -62.4% | -$16M | $-0.47 | - | - |
| 2019 | -$10M | -101.5% | -$10M | $-1.59 | - | - |
| 2018 | $627M | - | -$112M | $87.18 | - | - |
See NAUT's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs NAUT Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare NAUT vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonNAUT — Frequently Asked Questions
Quick answers to the most common questions about buying NAUT stock.
Is NAUT growing earnings?
NAUT EPS is $-0.45, with earnings growth accelerating to +16.1%. This exceeds the 5-year CAGR of N/A. TTM net income reached $-57M.
What are NAUT's profit margins?
Nautilus Biotechnology, Inc. net margin is N/A, with operating margin at N/A. Below-average margins reflect competitive or cost pressures.
How consistent are NAUT's earnings?
NAUT earnings data spans 2018-2025. The accelerating earnings trend is +16.1% YoY. Historical data enables comparison across business cycles.